Medicine Man Technologies provides an investor presentation summarizing their business. They offer cannabis consulting services, cultivation techniques, and nutrient products across multiple states. The presentation highlights their recent financial results, new clients, federal policy developments, and growth strategy through acquisitions. Medicine Man Technologies aims to be a leading cannabis brand and consulting company in the United States and internationally.
Green Spirit Industries plans to develop and operate medical cannabis dispensaries in Puerto Rico and California. It intends to acquire two dispensaries in California in Q1 2018 and operate three dispensaries in Puerto Rico by Q4 2017. Green Spirit will also operate cultivation facilities in Oakland and Desert Hot Springs, California, producing cannabis oils for manufacturing by Q2 2018. The presentation provides financial projections and details on the cannabis markets in Puerto Rico, California, and other states that have legalized medical or recreational use.
Cannabis Investor Pitch Deck Template consists of 31 power point slides covering the essential parts.
https://cannabusinessplans.com/product/cannabis-investor-pitch-deck-template/
This is a report on the cannabis market in the United States and the growth that is going to take place over the next 5 years. The Medical and adult use marijuana market are set to explode and we think that American Cannabis Company will benefit directly from this "green rush"
CannLabs presentation from WeedStock Investor Conference 2014CannLabs
CannLabs CEO, Genifer Murray and COO, Steve Kilts recently tag-teamed in a presentation at the Weedstock Conference hosted in Denver on June 30-July 1st, 2014. They discussed the current state of testing in the cannabis industry and their vision for the Company as the industry evolves. Their presentation was standing room only at this first annual event, and we wanted to share their presentation deck for those who were unable to attend.
Business Planning - Step by Step: Create a Great Plan Through Reliable Financ...Cannabis Legal Group
The document provides guidance on developing an effective business plan for obtaining a medical marijuana license. It outlines key components to include such as executive summaries, financial projections, market analyses, and operating procedures. Regulators may use the business plan against the applicant, so it is important to be conservative in projections and detailed while keeping it brief. The document also provides sample data and projections from other states that can be analyzed for the Michigan market.
Medicine Man Technologies provides cannabis consulting services and products to cannabis growers nationwide and internationally. Their services include consulting, cultivation optimization through their Cultivation Max program, and cannabis nutrients sold under the Success Nutrients brand. Medicine Man has acquired companies to expand their product and service offerings and pursue a strategy of building a "cannabis brand warehouse". They have experienced rapid revenue growth in recent years and expect new acquisitions and cross-selling opportunities to further drive sustainable revenue growth.
This document discusses the management and regulation of the legal recreational marijuana industry in Colorado. It outlines Amendment 64 which legalized personal use and cultivation of marijuana in Colorado. It then discusses the economic benefits of legalization, challenges around loopholes and changing laws, and how to properly plan, organize, lead, and control a marijuana business in compliance with regulations. Key aspects include educating customers, tracking finances and taxes, monitoring standards, and adapting to a changing legal and social environment. With strict enforcement of regulations, the industry has potential for significant economic benefits and revenue for the state.
A full business plan template package is everything you need to create a professional business plan for a Hemp CBD vertically integrated business with expert financials and projections.
https://hempcbdbusinessplans.com/product/hemp-cbd-vertically-integrated-business-plan-template/
Green Spirit Industries plans to develop and operate medical cannabis dispensaries in Puerto Rico and California. It intends to acquire two dispensaries in California in Q1 2018 and operate three dispensaries in Puerto Rico by Q4 2017. Green Spirit will also operate cultivation facilities in Oakland and Desert Hot Springs, California, producing cannabis oils for manufacturing by Q2 2018. The presentation provides financial projections and details on the cannabis markets in Puerto Rico, California, and other states that have legalized medical or recreational use.
Cannabis Investor Pitch Deck Template consists of 31 power point slides covering the essential parts.
https://cannabusinessplans.com/product/cannabis-investor-pitch-deck-template/
This is a report on the cannabis market in the United States and the growth that is going to take place over the next 5 years. The Medical and adult use marijuana market are set to explode and we think that American Cannabis Company will benefit directly from this "green rush"
CannLabs presentation from WeedStock Investor Conference 2014CannLabs
CannLabs CEO, Genifer Murray and COO, Steve Kilts recently tag-teamed in a presentation at the Weedstock Conference hosted in Denver on June 30-July 1st, 2014. They discussed the current state of testing in the cannabis industry and their vision for the Company as the industry evolves. Their presentation was standing room only at this first annual event, and we wanted to share their presentation deck for those who were unable to attend.
Business Planning - Step by Step: Create a Great Plan Through Reliable Financ...Cannabis Legal Group
The document provides guidance on developing an effective business plan for obtaining a medical marijuana license. It outlines key components to include such as executive summaries, financial projections, market analyses, and operating procedures. Regulators may use the business plan against the applicant, so it is important to be conservative in projections and detailed while keeping it brief. The document also provides sample data and projections from other states that can be analyzed for the Michigan market.
Medicine Man Technologies provides cannabis consulting services and products to cannabis growers nationwide and internationally. Their services include consulting, cultivation optimization through their Cultivation Max program, and cannabis nutrients sold under the Success Nutrients brand. Medicine Man has acquired companies to expand their product and service offerings and pursue a strategy of building a "cannabis brand warehouse". They have experienced rapid revenue growth in recent years and expect new acquisitions and cross-selling opportunities to further drive sustainable revenue growth.
This document discusses the management and regulation of the legal recreational marijuana industry in Colorado. It outlines Amendment 64 which legalized personal use and cultivation of marijuana in Colorado. It then discusses the economic benefits of legalization, challenges around loopholes and changing laws, and how to properly plan, organize, lead, and control a marijuana business in compliance with regulations. Key aspects include educating customers, tracking finances and taxes, monitoring standards, and adapting to a changing legal and social environment. With strict enforcement of regulations, the industry has potential for significant economic benefits and revenue for the state.
A full business plan template package is everything you need to create a professional business plan for a Hemp CBD vertically integrated business with expert financials and projections.
https://hempcbdbusinessplans.com/product/hemp-cbd-vertically-integrated-business-plan-template/
Business Plan Sample for a Cannabis Cultivation Business Start-UpCannaBusinessPlans
This is the extraction from the Business Plan written for a cannabis cultivation business in Colorado. Find the decision for your business: cannabis business plans templates and financial models https://cannabusinessplans.com/shop/
A complete cannabis business plan package is everything you need to create a 100% legally compliant professional business plan for cannabis retail business with expert financials and projections.
https://cannabusinessplans.com/product/cannabis-dispensary-business-plan-template-profit/
CannaCult is a new cannabis cultivation company that plans to operate a 3,600 square foot facility in California. The company will apply for a cultivation license and aims to grow up to 500 plants concurrently across 11 strains from seedling to finished product. CannaCult intends to become a leading cultivator and supplier of high-quality cannabis in California by securing licensing, building its brand, and distributing its products statewide over the next five years.
Opportunity to get in on the ground floor of cannabis investment, with a Secured 12% Convertible Notes. Company is set for a 2019 NASDAQ IPO through Regulation A+ which has already been filed with the SEC.
This document proposes a partnership between Rx Logic and a funding partner to build out a pharmaceutical logistics business. It notes opportunities in the market as pharmaceutical manufacturers increasingly outsource logistics. The plan is to start operations in a 25,000 square foot Illinois facility, obtain necessary licensing, and pursue small-to-mid sized pharmaceutical clients. Over 5 years, the partners aim to expand operations and add services to increase space, customers, revenue and profitability.
Protecting & Building Your Cannabis BrandJames Creedon
On March 9, 2019, James Creedon joined Richard Cheng of DLA Piper to discuss the many legal issues to consider when starting or growing a business in the cannabis industry. This presentation, hosted by the Texas Cannabis Business Alliance, was attended by a wide variety of entrepreneurs at the Communion Neighborhood Cooperative and was divided into three sections:
The first section was an overview of the current legal status of cannabis laws and regulations on the federal and state level, and included discussion of legislation pending in the U.S. Congress and the Texas legislature. The second section used an example business to walk through the immediate challenges faced by cannabis industry companies in Texas, addressing topics such as the legal status of CBD, industrial hemp farming, and the Texas Compassionate Use program. The final section identified the importance of good business practices and the use of resources such as the TCBA to connect with other industry members and start informed on changes in the law.
For more information about this presentation, please contact us by email at contact@creedonpllc.com or by phone at 972-850-6864.
Future of Cannabis Delivery Business - NetworkONVishal Sinhasan
Cannabis delivery business needs to optimize delivery and dispatch software to ensure all deliveries are fulfilled in time and to the right customer.
https://networkon.io/resources/blog/future-of-cannabis-delivery-business/
Before you start writing your marijuana business plan, spend as much time as you can to reading through some samples of a farm and food production business plans. Not only will that give you a good idea of what it is you’re aiming for, but it will also show you the different sections that different entrepreneurs include and the language they use to write about themselves and their future plans.
We have created a sample marijuana business plan example for you to get a good idea about how a perfect marijuana business plan should look like and what details you should include in your business plan.
Source: https://upmetrics.co/template/marijuana-business-plan-example
Your CBD business plan has to cover a lot of ground. Regulatory hurdles. Supply chain inconsistency. Marketing restrictions. And even if all those issues are addressed, you still have to create a credible brand in a crowded marketplace.
Fortunately, GemmaCert is here to help. We’ve assembled this guide with valuable information for creating a great CBD business. Because our executive team has extensive experience in the dietary supplement industry — and because CBD is regulated like a dietary supplement in many
jurisdictions — we can help CBD businesses navigate the market.
Kaleidoscope Software & Services provides integrated software and business services to help small and medium cannabis businesses succeed. Their proprietary software and 50 years of industry experience help cannabis companies increase efficiencies by up to 30% and profits by up to 13%. Kaleidoscope aims to expand their client base and services across multiple states to capitalize on the growing $13 billion legal cannabis industry.
Tyson Foods had mixed financial results in 2008. While sales increased, gross profit and operating income declined due to high input costs for chicken. However, strong performances from the pork and beef segments kept the company profitable overall. Tyson has made progress expanding internationally through acquisitions in Brazil and joint ventures in India and China to capitalize on growing global demand for protein. The company is also pursuing innovative initiatives to convert non-prime products into higher margin fuels, pet foods, and nutraceuticals.
Latest Report Available at Advance Market Analytics, “Cannabis testing services Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
The document provides information on planning a medical marijuana business, including an overview of components of an effective business plan, strategies for market analysis and financial projections, and average costs and revenues. Key elements of a business plan include an executive summary, corporate summary, keys to success, pro forma financials, and marketing plan. Successful planning requires conservative estimates based on thorough investigation of reliable industry data sources.
What is the best way to apply for trademark protection on cannabis products or services? This presentation reviews the current state of the law, discusses the particularities of state and federal applications, walks through the methods trademark attorneys and trademark owners are using to apply for protection, and reviews the ethical issues to be aware of in the process. This presentation was first offered by James Creedon, Creedon PLLC (www.creedonpllc.com) at the 2018 Intellectual Property Law Seminar and Midyear Meeting of the Intellectual Property Law Section of the Oklahoma Bar Association.
An overview of the Texas and federal rules on hemp and associated products, including a review of the laws related to CBD, industrial hemp, and importation of cannabis products between states.
Marijuana: The #1 Profit Opportunity for Greenhouse Growers in the Next DecadeGGS Structures Inc.
The document discusses the potential opportunities for greenhouse growers in the cannabis industry over the next decade. It notes that the legal cannabis market in the US and Canada is projected to be worth $44 billion by 2020. It provides an overview of the medical cannabis programs in Canada and regulations for licensed producers. The document also discusses factors for greenhouse growers to consider such as ventilation, lighting, irrigation and computer controls if pursuing cannabis cultivation. It emphasizes doing research and evaluating what skills align with long-term goals before deciding to enter the emerging industry.
This document outlines an action plan for applying to become a licensed producer of medical cannabis under Health Canada's Marihuana for Medical Purposes Regulations. It provides instructions on filling out the 15-page application, hiring a qualified person in charge, making required security upgrades, and submitting the application to Health Canada. It also estimates the potential revenue of $1.3 million per year for a 2,000 square foot greenhouse. The goal is to help replace over 15,000 existing medical cannabis growers by March 2014.
This document brings together a set
of latest data points and publicly
available information relevant for
Healthcare Industry. We are very
excited to share this content and
believe that readers will benefit from
this periodic publication immensely.
Marijuana is still illegal under the Controlled Substances Act. Before businesses get ahead of themselves, understanding the risk associated with this federal law is important. There are also market entry barriers such as limited licensing and access to startup capital to contend with; obtaining business loans from banks may be difficult for this industry.
The document summarizes key aspects of new medical marijuana laws in Michigan, including the Medical Marihuana Facilities Licensing Act, Marijuana Tracking Act, and amendments to the Michigan Medical Marihuana Act. It discusses the five new license types created (grower, processor, provisioning center, secure transporter, testing facility). Municipalities can authorize some, all or none of these facilities and set an annual licensing fee of up to $5,000. Revenue from license fees and a 3% excise tax will provide funds to municipalities. Projections estimate millions of dollars in potential revenue for municipalities from this industry. Regulation provides for tracking from "seed to sale" to prevent diversion and enforce compliance.
Centric Health Corporation - Investor Presentation - May 2020SharePitch
Updated investor presentation for Centric Health Corporation (TSX: CHH). Updates include the competion of the Remedy'sRx acquisition and first quarter financial results.
New 2024 Cannabis Dispensary Investor Pitch Deck Template SampleCannaBusinessPlans
We offer a '70% ready to go' professional Cannabis Dispensary Pitch Deck Template for PowerPoint. The template is completely open and editable, and all you have to do is add your company information. https://cannabusinessplans.com/product/cannabis-dispensary-investor-pitch-deck-template/
Business Plan Sample for a Cannabis Cultivation Business Start-UpCannaBusinessPlans
This is the extraction from the Business Plan written for a cannabis cultivation business in Colorado. Find the decision for your business: cannabis business plans templates and financial models https://cannabusinessplans.com/shop/
A complete cannabis business plan package is everything you need to create a 100% legally compliant professional business plan for cannabis retail business with expert financials and projections.
https://cannabusinessplans.com/product/cannabis-dispensary-business-plan-template-profit/
CannaCult is a new cannabis cultivation company that plans to operate a 3,600 square foot facility in California. The company will apply for a cultivation license and aims to grow up to 500 plants concurrently across 11 strains from seedling to finished product. CannaCult intends to become a leading cultivator and supplier of high-quality cannabis in California by securing licensing, building its brand, and distributing its products statewide over the next five years.
Opportunity to get in on the ground floor of cannabis investment, with a Secured 12% Convertible Notes. Company is set for a 2019 NASDAQ IPO through Regulation A+ which has already been filed with the SEC.
This document proposes a partnership between Rx Logic and a funding partner to build out a pharmaceutical logistics business. It notes opportunities in the market as pharmaceutical manufacturers increasingly outsource logistics. The plan is to start operations in a 25,000 square foot Illinois facility, obtain necessary licensing, and pursue small-to-mid sized pharmaceutical clients. Over 5 years, the partners aim to expand operations and add services to increase space, customers, revenue and profitability.
Protecting & Building Your Cannabis BrandJames Creedon
On March 9, 2019, James Creedon joined Richard Cheng of DLA Piper to discuss the many legal issues to consider when starting or growing a business in the cannabis industry. This presentation, hosted by the Texas Cannabis Business Alliance, was attended by a wide variety of entrepreneurs at the Communion Neighborhood Cooperative and was divided into three sections:
The first section was an overview of the current legal status of cannabis laws and regulations on the federal and state level, and included discussion of legislation pending in the U.S. Congress and the Texas legislature. The second section used an example business to walk through the immediate challenges faced by cannabis industry companies in Texas, addressing topics such as the legal status of CBD, industrial hemp farming, and the Texas Compassionate Use program. The final section identified the importance of good business practices and the use of resources such as the TCBA to connect with other industry members and start informed on changes in the law.
For more information about this presentation, please contact us by email at contact@creedonpllc.com or by phone at 972-850-6864.
Future of Cannabis Delivery Business - NetworkONVishal Sinhasan
Cannabis delivery business needs to optimize delivery and dispatch software to ensure all deliveries are fulfilled in time and to the right customer.
https://networkon.io/resources/blog/future-of-cannabis-delivery-business/
Before you start writing your marijuana business plan, spend as much time as you can to reading through some samples of a farm and food production business plans. Not only will that give you a good idea of what it is you’re aiming for, but it will also show you the different sections that different entrepreneurs include and the language they use to write about themselves and their future plans.
We have created a sample marijuana business plan example for you to get a good idea about how a perfect marijuana business plan should look like and what details you should include in your business plan.
Source: https://upmetrics.co/template/marijuana-business-plan-example
Your CBD business plan has to cover a lot of ground. Regulatory hurdles. Supply chain inconsistency. Marketing restrictions. And even if all those issues are addressed, you still have to create a credible brand in a crowded marketplace.
Fortunately, GemmaCert is here to help. We’ve assembled this guide with valuable information for creating a great CBD business. Because our executive team has extensive experience in the dietary supplement industry — and because CBD is regulated like a dietary supplement in many
jurisdictions — we can help CBD businesses navigate the market.
Kaleidoscope Software & Services provides integrated software and business services to help small and medium cannabis businesses succeed. Their proprietary software and 50 years of industry experience help cannabis companies increase efficiencies by up to 30% and profits by up to 13%. Kaleidoscope aims to expand their client base and services across multiple states to capitalize on the growing $13 billion legal cannabis industry.
Tyson Foods had mixed financial results in 2008. While sales increased, gross profit and operating income declined due to high input costs for chicken. However, strong performances from the pork and beef segments kept the company profitable overall. Tyson has made progress expanding internationally through acquisitions in Brazil and joint ventures in India and China to capitalize on growing global demand for protein. The company is also pursuing innovative initiatives to convert non-prime products into higher margin fuels, pet foods, and nutraceuticals.
Latest Report Available at Advance Market Analytics, “Cannabis testing services Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
The document provides information on planning a medical marijuana business, including an overview of components of an effective business plan, strategies for market analysis and financial projections, and average costs and revenues. Key elements of a business plan include an executive summary, corporate summary, keys to success, pro forma financials, and marketing plan. Successful planning requires conservative estimates based on thorough investigation of reliable industry data sources.
What is the best way to apply for trademark protection on cannabis products or services? This presentation reviews the current state of the law, discusses the particularities of state and federal applications, walks through the methods trademark attorneys and trademark owners are using to apply for protection, and reviews the ethical issues to be aware of in the process. This presentation was first offered by James Creedon, Creedon PLLC (www.creedonpllc.com) at the 2018 Intellectual Property Law Seminar and Midyear Meeting of the Intellectual Property Law Section of the Oklahoma Bar Association.
An overview of the Texas and federal rules on hemp and associated products, including a review of the laws related to CBD, industrial hemp, and importation of cannabis products between states.
Marijuana: The #1 Profit Opportunity for Greenhouse Growers in the Next DecadeGGS Structures Inc.
The document discusses the potential opportunities for greenhouse growers in the cannabis industry over the next decade. It notes that the legal cannabis market in the US and Canada is projected to be worth $44 billion by 2020. It provides an overview of the medical cannabis programs in Canada and regulations for licensed producers. The document also discusses factors for greenhouse growers to consider such as ventilation, lighting, irrigation and computer controls if pursuing cannabis cultivation. It emphasizes doing research and evaluating what skills align with long-term goals before deciding to enter the emerging industry.
This document outlines an action plan for applying to become a licensed producer of medical cannabis under Health Canada's Marihuana for Medical Purposes Regulations. It provides instructions on filling out the 15-page application, hiring a qualified person in charge, making required security upgrades, and submitting the application to Health Canada. It also estimates the potential revenue of $1.3 million per year for a 2,000 square foot greenhouse. The goal is to help replace over 15,000 existing medical cannabis growers by March 2014.
This document brings together a set
of latest data points and publicly
available information relevant for
Healthcare Industry. We are very
excited to share this content and
believe that readers will benefit from
this periodic publication immensely.
Marijuana is still illegal under the Controlled Substances Act. Before businesses get ahead of themselves, understanding the risk associated with this federal law is important. There are also market entry barriers such as limited licensing and access to startup capital to contend with; obtaining business loans from banks may be difficult for this industry.
The document summarizes key aspects of new medical marijuana laws in Michigan, including the Medical Marihuana Facilities Licensing Act, Marijuana Tracking Act, and amendments to the Michigan Medical Marihuana Act. It discusses the five new license types created (grower, processor, provisioning center, secure transporter, testing facility). Municipalities can authorize some, all or none of these facilities and set an annual licensing fee of up to $5,000. Revenue from license fees and a 3% excise tax will provide funds to municipalities. Projections estimate millions of dollars in potential revenue for municipalities from this industry. Regulation provides for tracking from "seed to sale" to prevent diversion and enforce compliance.
Centric Health Corporation - Investor Presentation - May 2020SharePitch
Updated investor presentation for Centric Health Corporation (TSX: CHH). Updates include the competion of the Remedy'sRx acquisition and first quarter financial results.
New 2024 Cannabis Dispensary Investor Pitch Deck Template SampleCannaBusinessPlans
We offer a '70% ready to go' professional Cannabis Dispensary Pitch Deck Template for PowerPoint. The template is completely open and editable, and all you have to do is add your company information. https://cannabusinessplans.com/product/cannabis-dispensary-investor-pitch-deck-template/
GET IN ON THE GROUND FLOOR OF CANNABIS INVESTMENT
WITH CBDZ SECURED CONVERTIBLE 8% NOTES
Cannabinoid Biosciences Inc. (CBDZ) is the first-female controlled Cannabis IPO in the United States and Canada.
CBDZ is offering a Secured Convertible Note paying 12% annual interest.
A $1,000 Note is convertible into 80 shares of CBDZ Common Stock which is currently being registered with the SEC under Reg. A+, to be sold at $10 per share.
The minimum investment is $1,000 per unit of our Secured 8% Convertible Notes offered under Reg. D 506 (c).
CBDZ has agreed to buy 10 dispensaries with $54 million in annual revenue from their current owners for $49 million. The consolidation rollup would do IPO on the NASDAQ or NYSE and Canadian Securities Exchange (CSE).
Once CBDZ successfully listed on the NASDAQ, a $1,000 investment could fetch a lot more because NASDAQ and NYSE market-participants pay $131 - $215 for $1 of sale for rollup/consolidated Cannabis business.
The document provides an investor update and presentation for Medicine Man Technologies in December 2017. It summarizes the company's financial performance, services, growth strategy, and management team. Medicine Man is a leading cannabis consulting company with a growing national and international presence. It provides consulting, cultivation optimization, educational resources, and nutrient products to cannabis growers. The company pursues an acquisition strategy to expand its product offerings and accelerate revenue growth across its business lines.
The document is an investor presentation by Tumbleweed Holdings, Inc. describing the company's business strategy and goals. Tumbleweed aims to build businesses in the legal cannabis and related sectors, targeting operations in science, technology, and data that support the cannabis industry. The company's strategic focus is on cannabis "business intelligence" services including data, technology, and science. Tumbleweed plans to use cannabis testing labs as the operating foundation for its corporate strategy, with the goal of establishing a national footprint through scalable and repeatable business models.
- McKesson Corporation reported strong financial performance for fiscal year 2005, with revenue growth of 16% to $80.5 billion, driven by new contracts with the VA and Caremark. Excluding litigation settlements, earnings were $2.19 per share.
- The company transitioned agreements with pharmaceutical manufacturers to deliver more predictable compensation and address issues when price increases fell below expectations. Record operating cash flow of $1.5 billion strengthened the balance sheet.
- Business segments saw growth in pharmaceutical distribution and alternate site medical supplies, while profits in medical-surgical solutions were reduced by litigation and lack of flu vaccine. Software bookings reached record levels and implementations accelerated.
- McKesson Corporation reported strong financial performance for fiscal year 2005, with revenue growth of 16% to $80.5 billion, driven by new contracts with the VA and Caremark. Excluding litigation costs, earnings were $2.19 per share.
- The company transitioned agreements with pharmaceutical manufacturers to deliver more predictable compensation and address issues when drug price increases fell below expectations.
- All business segments grew, with the exception of Medical-Surgical Solutions which was impacted by lack of flu vaccine and litigation costs. Pharmaceutical Solutions and Provider Technologies performed well.
This document brings together a set
of latest data points and publicly
available information relevant for
Healthcare Industry. We are very
excited to share this content and
believe that readers will benefit from
this periodic publication immensely.
Health Insurance Innovations Inc, HIIQ Investor Presentation released on March 2019. This Health Insurance Innovations investor relations slideshow covers the following topics:
-HIIQ Solution
-HIIQ Partners
-HIIQ Market Opportunity
-HIIQ New Initiatives
-HIIIQ Community Involvement
-HIIQ Financial Results
-HIIQ Solid Growth Trajectory
and much more.
Hemp Based Products Market: Outline
The use of hemp in various products and applications is rising at a great rate over the years. The medicinal benefits of hemp are tremendous and this aspect may bring substantial growth opportunities for the global hemp based products market during the forecast period of 2020-2030.
Cardinal Health reported an 11% increase in revenue to $24 billion for the first quarter. Earnings per share declined 16% to $0.69 due to contract re-pricings and anti-diversion efforts. The healthcare supply chain services segment achieved double-digit revenue growth but profit declined 16% due to pricing issues. Clinical and medical products revenue grew 12% and profits grew 15% driven by continued strength in dispensing. Cardinal Health reiterated its full-year guidance range despite economic uncertainty.
CannaCult is a new cannabis cultivation company seeking funding to start operations in California. They will grow 11 strains of cannabis in a 7,200 square foot greenhouse and have the capacity to grow 500 plants. CannaCult projects generating over $3 million in annual revenue within 5 years. They have a management team with experience in cannabis and agriculture and plan to utilize cutting edge technology like greenhouses to reduce costs. CannaCult expects to become profitable in the first year of operations and reinvest profits into expanding cultivation capacity to meet growing demand in the California cannabis market.
Hemp CBD Vertically Integrated Business Pitch Deck will help you to prepare your presentation to potential investors, because raising money from investors for your growing startup is challenging at any stage and requires a great pitch.
https://hempcbdbusinessplans.com/product/investor-pitch-deck-template-hemp-cbd-vertically-integrated-business/
This document brings together a set
of latest data points and publicly
available information relevant for
Healthcare Industry. We are very
excited to share this content and
believe that readers will benefit from this periodic publication immensely.
The document summarizes information from the Fallon Community Health Plan's (FCHP) December 2009 newsletter. It discusses FCHP's high rankings in national quality surveys. It also discusses ongoing efforts to reduce rising healthcare costs, including working with providers and employers. FCHP is focused on delivering value and ensuring members receive high quality care.
The document provides an overview of The Clorox Company's Q3 FY17 investor presentation. Key points include:
- Clorox has an advantaged portfolio with over 80% of sales from #1 or #2 share brands across cleaning, household, lifestyle, and international categories.
- The company is focused on strategies like innovation, digital transformation, and an engaged growth culture to drive sales growth of 3-5% annually.
- For FY17, Clorox expects sales growth of 3-4% and earnings per share growth of 7-9%, supported by factors like innovation, the Renew Life acquisition, and cost savings.
- Long-term, Clorox aims
Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives
Windfire Capital Corp. (“Windfire”) is publicly traded company, and the company is led by an experienced management team comprised of public market professionals and skilled operational people from the Medical Marijuana industry.
Windfire has executed definitive agreement with Rosebud Productions Inc., (“Rosebud”) located in British Columbia. Rosebud has submitted an application to Health Canada to become a LP of Medical Marijuana under the new MMPR .
Nvta q3 2016 earnings final final fina lv2invitaeir
Invitae Corporation held its third quarter earnings call on November 7, 2016. The company reported approximately 200% year-over-year growth in test volume, with 15,200 billable reports in the quarter. Invitae has expanded its genetic testing to over 1,000 genes and increased its in-network health plan coverage to over 160 million covered lives. The company's execution has positioned it to continue driving revenue growth and achieve positive cash flow by the end of 2018.
Kaleidoscope Software & Services provides software and business services to help cannabis companies succeed. Their proprietary integrated decision-making software and seed-to-sale techniques have increased client efficiencies by 30% and profits by 13%. The company currently serves six retail stores and seeks funding to expand their client base and software offerings to other states, develop applications for producers and processors, and provide strategic consulting services. The funding would allow Kaleidoscope to continue growing its multi-state, multi-service business in the cannabis industry.
Similar to Medicine Man Tech Presentation April 2018 (20)
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. With modest cash burn and a strong balance sheet, including $142.4 million cash and cash equivalents as of June 30, 2023, Zomedica is well-positioned to fund both organic growth and acquisitions.
Docola has developed a healthcare communication platform that utilizes asynchronous telehealth to deliver patient education and support. Their proprietary platform currently has over 55,000 patient users and over 1,100 clinician users. Docola seeks to raise up to $500,000 through a convertible note to fund working capital, research and development, and costs associated with an upcoming IPO.
- INNO Holdings is presenting an IPO investor presentation for an initial public offering on the NASDAQ Capital Market.
- The company manufactures prefabricated steel building components and systems using proprietary technology to reduce construction costs and environmental impact.
- INNO Holdings has four initial product lines - metal studs, prefabricated housing units, modular apartment buildings, and a mobile factory system. It aims to disrupt the construction industry through standardized, sustainable construction methods.
Everything Blockchain builds platforms of trust for the modern enterprise and is on a mission to ensure every organization has access to the tools and platforms that enable them to manage, store, and protect data without the cost and complexity that holds them back today. The Company’s patented advances in engineering deliver the essential elements needed for real-world business use: speed, security, and efficiency. Everything Blockchain’s current business lines include: EB Advise, Build DB and EB Control.
ASP Isotope is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries.
MDNA Life Sciences is a pioneer in the science of mitochondrial DNA. It’s our mission to create an extensive portfolio of proprietary tests that dramatically improve diagnosis, treatment, prognosis and monitoring. Putting an end to the unnecessary surgical procedures, pain and uncertainty that affect patients across the world.
Digital Ally, Inc. is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. The Company pursues an acquisition strategy that targets organizations with positive earnings, strong growth potential, innovation, and operational synergies. To maximize long-term shareholder value, Digital Ally intends to spin-off its ticketing and entertainment business lines into a separate public company in 2023. The spin-off will create two optimized, tech-driven public companies with strong growth opportunities and operating metrics.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
Aditxt is a biotech company developing immune monitoring and immune modulation platforms. Its AditxtScore platform can provide comprehensive immune profiles to monitor responses to pathogens, vaccines, drugs and transplants. Its Adimune platform aims to modulate the immune system to treat conditions like psoriasis, type 1 diabetes, and increase skin allograft survival. The company is working to develop, operate and commercialize these platforms. It currently generates revenue from immune monitoring tests and expects revenue from licensing deals for immune modulation programs as they advance in clinical trials towards commercialization.
1847 Holdings LLC, a publicly traded diversified acquisition holding company, was founded by Ellery W. Roberts, a former partner of Parallel Investment Partners, Saunders Karp & Megrue and Principal of Lazard Freres Strategic Realty Investors. EFSH's investment thesis is that capital market inefficiencies have left the founders and/or stakeholders of many small business enterprises and lower-middle market businesses with limited exit options, despite the intrinsic value of their business. Given this dynamic, EFSH can consistently acquire "solid" businesses for reasonable multiples of cash flow and then deploy resources to strengthen the infrastructure and systems to improve operations. These improvements may lead to a sale or IPO of an operating subsidiary at considerably higher valuations than the purchase price (as successfully demonstrated with the mid-2020 IPO of 1847 Goedeker on the NYSE American) and/or alternatively, an operating subsidiary may be held in perpetuity and contribute to EFSH's ability to pay regular and special dividends to shareholders.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. The Company has three core divisions: SolarJuice which has solar wholesale distribution, as well as residential solar and roofing installation and solar module manufacturing (Solar4America & SEM Wafertech), SPI Solar and Orange Power which operates a commercial & utility solar division, and the EdisonFuture/Phoenix Motor EV division. SolarJuice is the leader in renewable energy system solutions for residential and small commercial markets and has extensive operations in the Asia Pacific and North America markets. The SPI Solar commercial & utility solar division provides a full spectrum of EPC services to third party project developers, and develops, owns and operates solar projects that sell electricity to the grid in multiple regions, including the U.S., U.K., and Europe. Phoenix Motor is a leader in medium-duty commercial electric vehicles, and is developing EV charger solutions, electric pickup trucks, electric forklifts, and other EV products. SPI maintains global operations in North America, Australia, Asia and Europe and is also targeting strategic investment opportunities in fast growing green energy industries such as battery storage, charging stations, and other EVs which leverage the Company's expertise and substantial solar cash flow.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Genetic Technologies is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GENE offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
The E-Way Bill revolutionizes logistics by digitizing the documentation of goods transport, ensuring transparency, tax compliance, and streamlined processes. This mandatory, electronic system reduces delays, enhances accountability, and combats tax evasion, benefiting businesses and authorities alike. Embrace the E-Way Bill for efficient, reliable transportation operations.
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
Methanex is the world's largest producer and supplier of methanol. We create value through our leadership in the global production, marketing and delivery of methanol to customers. View our latest Investor Presentation for more details.
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4study presented by a Big 4
UnityNet World Environment Day Abraham Project 2024 Press ReleaseLHelferty
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdfSOFTTECHHUB
The world of blockchain and decentralized technologies is about to witness a groundbreaking event. ZKsync, the pioneering Ethereum Layer 2 network, has announced the highly anticipated airdrop of its native token, ZK. This move marks a significant milestone in the protocol's journey, empowering the community to take the reins and shape the future of this revolutionary ecosystem.
2. 2
This presentation may contain forward looking statements which are based on current expectations,
forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and
results to differ materially from those anticipated or expected, including statements related to the amount
and timing of expected revenues and any payment of dividends on our common and preferred stock,
statements related to our financial performance, expected income, distributions, and future growth for
upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and
reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the
timing of certain events could differ materially from those projected in or contemplated by the forward-
looking statements due to a number of factors detailed from time to time in our filings with the Securities
and Exchange Commission. Among other matters, Medicine Man Technologies may not be able to sustain
growth or achieve profitability based upon many factors including, but not limited to, general stock
market conditions. Reference is hereby made to cautionary statements set forth in the Company's most
recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of
our existing and new service lines, noting there is no assurance that we will generate enough revenues to
offset those costs in both the near and long term. Additional service offerings may expose us to additional
legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where
we will be providing services, the impact of which cannot be predicted at this time.
Safe Harbor Statement
3. Price: $2.02 (4/18 close)
Market Cap:* $48.7M
Shares Outstanding:* 24.09M
Avg. Vol (30 day): 48,628
2017 Revenues: $3.5M
Year-over-Year Revenue
Growth
459%
Exchange: OTCQB
Ticker: MDCL
Headquarters: Denver, CO
No. Employees: 21
Founded: 2014
(as of 04/18/18)
3
* Adjusted to reflect acquisitions, debt retirement, financings
At a Glance
Medicine Man Technologies is the leading
cannabis consultancy and product “brand
warehouse” company, with a rapidly expanding
presence in the U.S., and internationally.
4. Medicine Man Technologies Provides Q1 2018 Financial Outlook, New Client Updates, and Insight into Recent Federal Developments
DENVER, CO, April 16, 2018 --- Medicine Man Technologies Inc. (OTCQB: MDCL) (“Medicine Man Technologies” or “Company”), one of the
United States' leading cannabis branding and consulting companies today provided preliminary financial results for the quarter ended March 31, 2018, an
update on new client activity, and insight as to recent federal developments.
The Company projects having achieved revenue growth to approximately $1.2M in its first quarter, a 122% increase over the $541,000 as
reported in the comparable first quarter period in 2017, making this the fifth consecutive quarter on quarter revenue growth period achieved.
In addition, Medicine Man Technologies anticipates reaching an operational profit/loss breakeven point for the quarter and, the Company
repaid all its remaining debt in this quarter.
Since its last client update in early March of 2018, the Company has entered into five (5) new license and/or service agreements and is pleased to
highlight its single Iowa client’s win of two dispensary licenses, which was announced in late March by our client. Additionally, among the new license
agreements is substantial new Cultivation MAX Client in Nevada, which expects to begin construction around mid-year for the rehabilitation of over
100,000 SF of existing space.
Brett Roper, Medicine Man Technologies’ co-founder and CEO commented, “We are pleased with the solid operational results that we project for the
first quarter of 2018, highlighted by the achievement of a breakeven quarter, and believe that this performance has the Company firmly on track to
achieving its profit goals for the full year. As it relates to new client expansion, we continue to experience an increase in both US as well as international
inquiries, as the Company’s reputation and expanded client pipeline continues to evolve. As of this date we have several formal service proposals out to
prospective new clients in multiple states and expect our client base to continue to expand over time.”
Mr. Roper continued, “We are also pleased with the recent report of expected non-interference from the U.S. Department of Justice in Colorado’s
Cannabis marketplace, as such a commitment by the Trump administration to Senator Gardner would offer a defined path to the creation of an
overarching legal strategy related to states’ rights in determining their individual direction for Cannabis regulations and deployment. We anticipate that
this development will have a positive impact on the progress of Colorado House Bill 18-1011, allowing certain strictly defined ‘fully reporting’ public
companies to hold ownership in Colorado based Cannabis licenses. We are confident that this level of public company transparency would benefit the
industry and investors alike and provide a source of new capital to those businesses deserving of it.”
Andy Williams, Chairperson of Medicine Man Technologies’ Board of Directors added, “Yet again, Senator Cory Gardner has stepped up for Colorado
and made a positive impact on the cannabis industry. We applaud the work of the New Federalism Fund in educating Republicans like Senator Gardner
on marijuana-related issues. We look forward to continued pro-cannabis legal initiatives, including enacting the Cole memo into law instead of a
referendum, which we also believe holds the potential to fix issues facing the industry related to banking and 280e.“
Additionally, on the new client front, Medicine Man Technologies has entered into preliminary negotiations with one of its significant existing Canadian
partners to expand support to the Micro Grower community in Canada through offering enhanced access to the Company’s proprietary Three-A-Light ®
cultivation methods and Success Nutrients ® as a cornerstone of that new enterprise through an extended licensing arrangement.
Joshua Haupt, Medicine Man Technologies’ Chief Revenue Officer stated, “This market segment for cultivators will require a hyper competitive
footprint as it relates to the 2,000 SF canopy limitation and I believe that our current cultivation efficiency and performance will provide these talented
growers with a distinct advantage in achieving low cost production of quality tested ‘craft’ based cannabis to the marketplace in Canada. The craft side of
cultivation served as my onramp to the industry years ago and resulted in my creation of the Three-A-Light methodology. I look forward to working
with our licensees in Canada and across our growing client footprint to assist these entrepreneurs to achieve maximum efficiency in their gardens.”4
Press Release Update … 04/16/2018
5. 5
Core Services
Medicine Man provides value-added services to cannabis growers with a full suite of
complementary consulting, licensing, and product solutions that span the entire cannabis
industry supply chain
Consulting Services Cultivation Max “Three A Light” Success Nutrients
Supports client
application efforts to help
secure state-issued
operating and other
licenses, while building
relationship networks
across the industry
Utilizes industry leading
cultivation methodology
to enable existing
operators to optimize
facilities to improve grow
metrics
Leading cannabis
cultivation tutorial
provides step-by-step
marijuana growing from
seed to finished flower
Three part product line,
with six additional
additives, is a key and
required component to
maximizing the results of
the “Three A Light™”
cultivation methodology
and Cultivation Max
service
6. 6
States of Operations
- States in which the company is actively operating
Medicine Man has fee generating clients in 11 states and Puerto Rico, most recently
supporting an Ohio Level 1 application receiving the 2nd highest score. Internationally, the
Company also has clients in Australia, Canada, Germany, and South Africa.
7. 7
• 29 states and the District of Columbia allow their citizens to use medical cannabis
➢ In January 2018, Vermont’s legislature approved medical use
• Nine states: Colorado, Washington, Alaska, Oregon, California, Nevada, Maine,
Vermont and Massachusetts have approved legalization of cannabis for adult use
➢ Adult use sales in California launched on January 1, 2018
➢ Massachusetts adult use sales are expected to commence mid-2018.
• North American cannabis sales grew by more than 30% in 2017 to approximately
$10 billion as the legal market expanded, according to a December 2017 report by
Arcview Market Research.
➢ North American sales are projected to rise to $24.5 billion by 2021, up from
Arcview’s previous estimate of $20.2 billion, which was issued at the beginning
of 2017.
Cannabis Market Facts and Figures
8. 8
Cultivation Technology
Medicine Man Technologies represents Three-
A-Light®, the premier cultivator in the
Cannabis industry and has extensive expertise
in all areas of cannabis cultivation utilizing its
Variable Capacity Continuous Harvest
(“VVCH”) model.
Areas of cultivation expertise include:
➢ Cloning, Propagation
➢ Vegetative and Flowering husbandry
➢ Trimming, Drying and Cure techniques
Acquired “Three-A-Light” expertise from
Pono/Success Nutrients noting Medicine Man
Technologies is positioned as the gold standard
of cannabis cultivation.
Consultants possess an extensive knowledge of
cannabis plant metabolism and physiology,
indoor grow protocols and best practices, and
the processing of the harvested crop.
9. 9
Cultivation Max enables operators to compete
by optimizing an operators’ existing
cultivation facility to improve:
➢ Yield
➢ Consistency
➢ Quality
➢ Efficiency
Once initial designs and retrofits are
completed, Medicine Man monetizes its value
on the improvement delta and recurring
nutrients sales, creating a “Win-Win” for all
parties.
There are currently 11 Cultivation Max
Clients, 3 of which are in operation. The other
8 are anticipated to be in operation by the end
of 2018, representing over 180,000 pounds of
annual cannabis capacity.
Cultivation Max
10. 10
As an illustration of the potential revenue generation from the
Cultivation Max program, we apply the following general
good practice performance-based assumptions:
• Five (5) harvests per year, on average;
• A two (2) pound per light or 70 grams per square foot
of flower canopy baseline performance;
• Achieving three (3) pounds per light or an improvement
of at least one (1) pound per light or 35 grams per square
foot of flower
Based upon the above, and assuming we receive 15% of the
improvement delta and the wholesale value of flower is
$1,000 (net of taxes), we would receive $150 per light per
harvest in revenues or $750 per light annually.
For a 500 light facility (flowering), Medicine Man would
achieve $375,000 of gross revenues annually, while the client
would achieve $7.125M in wholesale revenues, an increase
of $2.125M over 2# per light, representing a 40% increase,
assuming stable or lower costs per pound from baseline.
Cultivation Max
11. 11
• Leading cannabis cultivation tutorial “Three A Light™” provides step-by-step
marijuana growing from seed to finished flower
➢ Simple approach to a complex process
• Book has sold 1,800 copies on Amazon and via direct sales. The list price is $500 per
copy.
“Three A Light”
12. 12
Success Nutrients™ features a three-part product line
that includes six additional additives, containing all the
micro/macro nutrients required to produce the strongest
yields while achieving the highest quality possible.
The line is a key component to maximizing the results
of the “Three A Light™” cultivation methodology. Its
goal is to revolutionize modern gardening, with an
emphasis on stronger plants, healthy flowers and an
overall cleaner product.
Success Nutrients line is now being carried in several new supply store groups in Colorado including Way to
Grow, Cultivate, Cost Plus Hydro, Grow Your Own, Grow Fax, Grow Masterz, Big Tomato, Hydro Shack and
The Hydro Store. In addition, an initial California presence with Pacific Coast Hydro, All Seasons Hydro and
Hydro Empire has been established and a broadening US and Canadian footprint is planned in the near future.
Success Nutrients
13. 13
Acquisition Strategy
Medicine Man seeks to acquire companies
that span the cannabis industry and can
support its product “Brand Warehouse”
strategy by:
➢ Accelerating its growth across all
product and service lines
➢ Augmenting or providing new lines of
products and services for the Company
to leverage and sell across its existing
installed customer base
➢ Supporting the Company’s national
and international expansion strategy
Current Brand Warehouse Includes:
15. 15
Synergistic Revenue Growth Drivers
SUCCESS
NUTRIENTS
CONSULTING /
LICENSE SUPPORT
CULTIVATION
MAX
“THREE A LIGHT”
• 2017 Revenues: $3.5 Million
(up 459% year-over-year)
• 2016 Revenues: $631,000
• Integration of new acquisitions,
utilizing IP and methodologies
across multiple offerings will
drive sustainable revenue
generating opportunities
16. 16
Brett Roper, Co-Founder and CEO
• Extensive background in business development, having successfully 'shepherded' Form 10/S1 filings and up-listing efforts
• Substantial real estate experience, managing acquisition, holding, and disposition of major industrial properties
• Active in providing design insights for cannabis related property deployment
• Served in several advisory roles, including as an independent board member, to other pre-IPO and public companies
Joshua Haupt, Chief Cultivation Officer
• Joined Medicine Man upon the acquisition of his companies Pono Publications and Success Nutrients, closed in June 2017
• Recognized for his innovative growing technique and entrepreneurship in the cannabis industry
• One of the largest growers in Colorado and aptly referred to as the “Steve Jobs of Marijuana”
• His book, “Three A Light”, has restructured growing methods in his own grow house, and now on an international level,
with cultivators all over the globe looking towards him for methods of production
• Has also founded Superfarm, Success Nutrients, and Tall T Productions
Andy Williams, Co-Founder and Chairperson of the Board
• History of leadership positions in a wide range of manufacturing industries as an industrial engineer
• Lifelong entrepreneur who, along with his brother Pete Williams, launched Medicine Man in December of 2009, with the
concept of being the Costco of cannabis, after the Ogden letter was published stating the Department of Justice would not
utilize prosecute individuals following state cannabis laws
• Eight years later, Medicine Man has emerged as an industry leader throughout the U.S. and has branched out to assist start
up cannabis companies and grow facilities across the country
Management Team
17. 17
Investment Highlights
• We perform as a value-add consultant to the general cannabis industry
• National and international service footprint, including 14 States, Canada, South
Africa, Germany, and Australia
• Year over year revenue growth over 459%, driven by acquisition and organically, with
five successive quarters of revenue growth
• Cultivation Max monetizes yield improvements derived by applying industry leading
cultivation “Three A Light” methodology
• Company is led by leading experts in the emerging cannabis market place including,
Andy Williams, Brett Roper and Josh Haupt, referred to as the “Steve Jobs of
Cannabis Cultivation”
• Acquisition strategy to drive a cannabis industry product “Brand Warehouse”, with
targets that accelerate and synergize revenue generation across the business
• Financial position strengthened by $1.6M in new equity capital and the recent
elimination of all debt
18. Thank You!
18
Contact:
Brett Roper, CEO
brett@medicinemantechnologies.com
Medicine Man Technologies
4880 HAVANA STREET, SUITE 201
DENVER, CO 80239
Tel: 303-371-0387